Leadership

Matthew Fox
Company Operations

Dr. Gregory R Stewart
Scientific Operations

Dr. Chani Maher
Managerial Oversight

Matthew Fox
CEO

As CEO, Matthew Fox is responsible for overseeing the company’s operations, developing the growth strategy, and delivering revenue and profitability. Prior to joining Pairnomix, Matthew served as Senior Vice President of Corporate Strategy at Upsher-Smith Laboratories, Inc., leading business intelligence efforts, developing and maintaining trade and advocacy partnerships, and sourcing new opportunities to expand and grow the business. Prior to that role, Matthew spent ten years professionally investing globally in biotechnology and pharmaceutical companies and served as a Portfolio Manager at Bank am Bellevue in Zurich, Switzerland. He holds a B.A. in Neuroscience and Behavior from Wesleyan University (CT).

Dr. Gregory R Stewart
Chief Scientific Officer

As Chief Scientific Officer, Dr. Gregory (Greg) Stewart, leads the scientific team at Pairnomix. He is responsible for developing the company's scientific strategies, including its external research and drug repurposing offerings, and internal development efforts. Greg also oversees the execution of all research activities, including experimental design, research progress, and delivery of findings. Prior to joining Pairnomix, Greg spent twenty years leading drug development efforts from the preclinical discovery phase to Phase II/III trials. Most recently, he served as a Vice President at Voyager Therapeutics and as Director of the CNS Drug Therapy Development Group at Medtronic. He earned his Ph.D. in Neural Sciences from Washington University in St. Louis and his B.S. in Neuroscience from Texas Christian University.

Dr. Chani Maher
Director of Business Operations

As Director of Business Operations, Dr. Chani Maher is responsible for executing the vision of the CEO and driving the day-to-day operating activities of Pairnomix. As such, she provides managerial oversight to all of the company’s functions and employees. Before serving in her current role, Chani worked as a consultant with Upsher-Smith Laboratories, Inc., coordinating with its internal business divisions to successfully spin out Pairnomix. She earned a Ph.D. in Neuroscience and an M.B.A. from the University of Minnesota, as well as a B.S. in Biomedical Sciences and a B.A. in Psychology from SUNY-Buffalo.